Patent delisted for Boehringer Ingelheim drug TRADJENTA
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are nine patents…
The post Patent delisted for Boehringer Ingelheim drug TRADJENTA…
Patent delisted for Boehringer Ingelheim drug TRADJENTA Read Post »